Biopharma Deal Metrics Declined Across The Board In 2024

 
• By Joseph Haas and Nancy Pham
  
Dealmaking metrics declined sharply in 2024 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Strategy